The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial).
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Roche (Inst); Secura Bio (Inst); Takeda (Inst)
Research Funding - 2Seventy bio (Inst); Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); C4 Therapeutics (Inst); CARsgen Therapeutics (Inst); Cartesian Therapeutics (Inst); Celgene (Inst); Celularity (Inst); crispr therapeutics (Inst); EMD Serono (Inst); Fate Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Incyte (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst)
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Legend Biotech
Research Funding - AMGEN (Inst); Janssen Oncology (Inst); Sanofi (Inst)
 
Adriana Rossi
No Relationships to Disclose
 
James H. Essell
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; Caribou Biosciences
Speakers' Bureau - Bristol-Myers Squibb; Kite, a Gilead Company
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Honoraria - GlaxoSmithKline; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celularity; Janssen Oncology; Merck; Neximmune; Pepticom
 
Sham Mailankody
Honoraria - OncLive/MJH Life Sciences; Physicans' Education Resource; Plexus
Consulting or Advisory Role - Janssen Oncology; Legend Biotech; Optum; Optum
Research Funding - Alimera Sciences (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics; Fate Therapeutics; Janssen Oncology (Inst); Juno Therapeutics (Inst); Takeda (Inst)
 
Neeraj Saini
No Relationships to Disclose
 
Houston Holmes
Leadership - Exuma Biotech
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene/Juno; Celgene; crispr therapeutics; Epizyme; Genentech; Janssen; Karyopharm Therapeutics; Kite/Gilead; Rigel; TG Therapeutics
Speakers' Bureau - Dova Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Rigel; Seagen
Research Funding - ADC Therapeutics (Inst); Adicet Bio (Inst); Allogene Therapeutics (Inst); Artiva (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene (Inst); Caribou Biosciences (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); MorphoSys (Inst); Novartis (Inst); Precision Biosciences (Inst); Viracta Therapeutics (Inst)
 
Binod Dhakal
Honoraria - Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Amgen; Arcellx; Genentech/Roche; GlaxoSmithKline; Janssen Oncology; Natera; Pfizer; Sanofi; Takeda
Speakers' Bureau - Janssen Oncology
Research Funding - Amgen (Inst); Arcellx (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Sanofi (Inst)
 
Cristina J. Gasparetto
No Relationships to Disclose
 
Samir S. Parekh
Consulting or Advisory Role - Foundation Medicine
Research Funding - Amgen; Celgene; Karyopharm Therapeutics; Pfizer
 
Socorro Portella
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Guy Ledergor
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Ashley Hammad
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Franco Davi
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Justin Skoble
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Elizabeth Garner
Employment - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Steven Brian Kanner
Employment - Caribou Biosciences
Leadership - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Syed Rizvi
Employment - Caribou Biosciences
Leadership - Caribou Biosciences
Stock and Other Ownership Interests - Caribou Biosciences
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Legend Biotech; Regeneron; Sanofi; Takeda
Travel, Accommodations, Expenses - Brystol-Myers Squibb; Janssen Biotech